Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering Donepezil.

Client Email

Product

Donepezil
CAS 120014-06-4
CAS 120011-70-3
CAS 120014-30-4
CAS 120013-39-0
5 6-Dimethoxy-1-Indanone
CAS 145546-80-1
CAS 2107-69-9
CAS 4803-74-1
HEALTH CANADA PATENTS

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Gonane Donepezil

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

Contact Supplier

Axplora- The partner of choice for complex APIs.

Contact Supplier

Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Contact Supplier

Donepezil

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

74 API Suppliers, 32 USDMF, 11 CEP/COS, 16 JDMF, 23 EU WC, 70 KDMF, 22 NDC API, 37 Listed Suppliers, $ API Reference Price

74 API Suppliers
32 USDMF
11 CEP/COS
16 JDMF
23 EU WC
70 KDMF
22 NDC API
37 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

30 API Suppliers

30 API Suppliers

FINISHED DOSAGE FORMULATIONS

582 FDF Dossiers, 99 FDA Orange Book, 302 Europe, 44 Canada, 32 Australia, 30 South Africa, 75 Listed Dossiers

582 FDF Dossiers
99 FDA Orange Book
302 Europe
44 Canada
32 Australia
30 South Africa
75 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 5MG, TABLET, ORALLY DISINTEGRATING;ORAL - 10MG, TABLET, ORALLY DISINTEGRATING;ORAL - 5MG, TABLET;ORAL - 23MG

TABLET;ORAL - 10MG
TABLET;ORAL - 5MG
TABLET, ORALLY DISINTEGRATING;ORAL - 10MG
TABLET, ORALLY DISINTEGRATING;ORAL - 5MG
TABLET;ORAL - 23MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Evonik, 5 Rochem International Inc, 18 SPI Pharma, 2 Seqens, 20 DKSH, 3 Jai Radhe Sales, 2 Pharm-RX Chemical, 8 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 15 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 35 BASF, 1 Bioplus Life Sciences, 2 Clariant, 15 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 13 Gangwal Chemicals, 16 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 33 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 21 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

102 Fillers, Diluents & Binders, 76 Coating Systems & Additives, 47 Direct Compression, 47 Controlled & Modified Release, 46 Disintegrants & Superdisintegrants, 41 Thickeners and Stabilizers, 38 Solubilizers, 31 Granulation, 26 Taste Masking, 26 Lubricants & Glidants, 25 Parenteral, 24 Topical, 21 Film Formers & Plasticizers, 20 Co-Processed Excipients, 20 Chewable & Orodispersible Aids, 12 Emulsifying Agents, 10 Rheology Modifiers, 9 Empty Capsules, 9 API Stability Enhancers, 6 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

102 Fillers, Diluents & Binders
76 Coating Systems & Additives
47 Direct Compression
47 Controlled & Modified Release
46 Disintegrants & Superdisintegrants
41 Thickeners and Stabilizers
38 Solubilizers
31 Granulation
26 Taste Masking
26 Lubricants & Glidants
25 Parenteral
24 Topical
21 Film Formers & Plasticizers
20 Co-Processed Excipients
20 Chewable & Orodispersible Aids
12 Emulsifying Agents
10 Rheology Modifiers
9 Empty Capsules
9 API Stability Enhancers
6 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 65 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
65 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 268 Finished Drug Prices, 8 Annual Reports

4 US Medicaid Prescriptions
268 Finished Drug Prices
8 Annual Reports

MARKET PLACE

13 APIs, 3 FDF Dossiers

13 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

77 US Patents, 2 US Exclusivities, 8 Health Canada Patents

77 US Patents
2 US Exclusivities
8 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 USP, 7 JP, 12 Others

4 USP
7 JP
12 Others

ANALYTICAL

3 BioAnalytical Methods, 9 Analytical Methods

3 BioAnalytical Methods
9 Analytical Methods

$ API Ref.Price (USD/KG) : 1,855 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

8 All

01 8Pfizer Canada Inc.

filter Patent Reset all filters

8 All

01 41338808

02 42252806

filter Product Reset all filters

8 All

01 8Donepezil Hydrochloride

filter Dosage Reset all filters

8 All

01 4Rapidly Disintegrating Tablet

02 4Tablet

filter Exp Date Reset all filters

8 All

01 42013-12-24

02 42017-06-06

US Patents
US Exclusivities
Health Canada Patents

Product Main Page

01

Pfizer Canada Inc.

Donepezil

Luxepack

Not Confirmed

Pfizer Canada Inc.

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-06-06

Date Granted : 2005-11-22

Brand Name : ARICEPT

Patent Number : 2252806

Filing Date : 1997-06-06

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-06-06

Date Granted : 2005-11-22

Portfolio PDF

Product Web Link

Digital Content

02

Pfizer Canada Inc.

Donepezil

Luxepack

Not Confirmed

Pfizer Canada Inc.

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-06-06

Date Granted : 2005-11-22

Brand Name : ARICEPT

Patent Number : 2252806

Filing Date : 1997-06-06

Strength per Unit : 10 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-06-06

Date Granted : 2005-11-22

Portfolio PDF

Product Web Link

Digital Content

03

Pfizer Canada Inc.

Donepezil

Luxepack

Not Confirmed

Pfizer Canada Inc.

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-06-06

Date Granted : 2005-11-22

Brand Name : ARICEPT RDT

Patent Number : 2252806

Filing Date : 1997-06-06

Strength per Unit : 5 mg

Dosage Form : Rapidly Disintegrating Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-06-06

Date Granted : 2005-11-22

Portfolio PDF

Product Web Link

Digital Content

04

Pfizer Canada Inc.

Donepezil

Luxepack

Not Confirmed

Pfizer Canada Inc.

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-12-24

Date Granted : 1996-12-24

Brand Name : ARICEPT RDT

Patent Number : 1338808

Filing Date : 1988-06-21

Strength per Unit : 5 mg

Dosage Form : Rapidly Disintegrating Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-12-24

Date Granted : 1996-12-24

Portfolio PDF

Product Web Link

Digital Content

05

Pfizer Canada Inc.

Donepezil

Luxepack

Not Confirmed

Pfizer Canada Inc.

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-06-06

Date Granted : 2005-11-22

Brand Name : ARICEPT RDT

Patent Number : 2252806

Filing Date : 1997-06-06

Strength per Unit : 10 mg

Dosage Form : Rapidly Disintegrating Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-06-06

Date Granted : 2005-11-22

Portfolio PDF

Product Web Link

Digital Content

06

Pfizer Canada Inc.

Donepezil

Luxepack

Not Confirmed

Pfizer Canada Inc.

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-12-24

Date Granted : 1996-12-24

Brand Name : ARICEPT RDT

Patent Number : 1338808

Filing Date : 1988-06-21

Strength per Unit : 10 mg

Dosage Form : Rapidly Disintegrating Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-12-24

Date Granted : 1996-12-24

Portfolio PDF

Product Web Link

Digital Content

07

Pfizer Canada Inc.

Donepezil

Luxepack

Not Confirmed

Pfizer Canada Inc.

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-12-24

Date Granted : 1996-12-24

Brand Name : ARICEPT

Patent Number : 1338808

Filing Date : 1988-06-21

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-12-24

Date Granted : 1996-12-24

Portfolio PDF

Product Web Link

Digital Content

08

Pfizer Canada Inc.

Donepezil

Luxepack

Not Confirmed

Pfizer Canada Inc.

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-12-24

Date Granted : 1996-12-24

Brand Name : ARICEPT

Patent Number : 1338808

Filing Date : 1988-06-21

Strength per Unit : 10 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-12-24

Date Granted : 1996-12-24

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?